Related Experiment Videos
Non-compliance with psychotropic medication
L S Gillis1, D Trollip, A Jakoet
1Department of Psychiatry, University of Cape Town.
Summary
Psychiatric medication non-compliance affects at least half of patients, particularly younger males and minority groups. Poor understanding of treatment by relatives contributes to this persistent issue over two years.
Area of Science:
- Psychiatry
- Clinical Psychology
- Pharmacology
Background:
- Psychotropic medication non-compliance is a significant challenge in psychiatric care.
- Understanding factors influencing compliance is crucial for treatment success.
Purpose of the Study:
- To investigate the prevalence and patterns of psychotropic medication non-compliance over a 2-year period.
- To identify demographic and social factors associated with non-compliance.
- To explore reasons for non-compliance and potential areas for intervention.
Main Methods:
- A 2-year follow-up study involving 406 patients discharged from a psychiatric hospital.
- Data collection on medication compliance, demographics, and understanding of treatment.
- Analysis of compliance rates across different medication types, demographics, and time points.
Main Results:
- At least half of patients exhibited non-compliance with psychotropic medication.
- Non-compliance was higher in black and coloured patients with oral phenothiazine compared to white patients.
- Younger patients and males showed higher rates of non-compliance.
- Poor understanding of medication by relatives was noted, especially in black and coloured patient families.
- Key reasons for non-compliance included resistance, side-effects, and clinic non-attendance.
Conclusions:
- Non-compliance with psychotropic medication is a persistent issue in psychiatric patients.
- Demographic factors, medication type, and poor family understanding significantly impact compliance.
- Targeted interventions addressing patient resistance, side-effects, and improving family education are needed to enhance treatment adherence.